Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (151-160 of 372) with videos related to

Pageof 38
Sort By:
Forum (Genoa, Italy)|March 23, 2011
Recurrent liver disease after liver transplantationMario Rizzetto, Thomas E Starzl, Luigi Rainero Fassati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2011
Liver precancerous lesions and hepatocellular carcinoma: the histology reportMassimo Roncalli, Luigi Terracciano, Luca Di Tommaso, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 23, 2011
Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinomaDidier Samuel, Massimo Colombo, Hachem El-Serag, et al.
American Journal of Obstetrics and Gynecology|February 21, 2002
Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control studyAstrid Scalori, Alessandra Tavani, Silvano Gallus, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2008
Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin?Maria Francesca Donato, Francesca Agnelli, Cristina Rigamonti, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2022
Editorial: global liver fat accumulation and global health-towards a sustainable development goal. Authors' replyJeffrey V Lazarus, Henry E Mark, Mary E Rinella, et al.
The American Journal of Gastroenterology|October 3, 2002
Risk factors for focal nodular hyperplasia of the liver: an Italian case-control studyAstrid Scalori, Alessandra Tavani, Silvano Gallus, et al.
Tumori|April 16, 2009
Estimates of the incidence and prevalence of hepatocellular carcinoma in Italy in 2002 and projections for the years 2007 and 2012Cristina Bosetti, Cosetta Bianchi, Eva Negri, et al.
Hepatitis Monthly|August 11, 2012
Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft ReinfectionAlessio Aghemo, Sherrie Bhoori, Stella De Nicola, et al.
Blood|January 25, 2002
Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapyElena Santagostino, Maria Grazia Rumi, Monica Rivi, et al.
Pageof 38

Showing results (151-160 of 372) with videos related to

Sort By:
Pageof 38
Forum (Genoa, Italy)|March 23, 2011
Recurrent liver disease after liver transplantationMario Rizzetto, Thomas E Starzl, Luigi Rainero Fassati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2011
Liver precancerous lesions and hepatocellular carcinoma: the histology reportMassimo Roncalli, Luigi Terracciano, Luca Di Tommaso, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 23, 2011
Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinomaDidier Samuel, Massimo Colombo, Hachem El-Serag, et al.
American Journal of Obstetrics and Gynecology|February 21, 2002
Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control studyAstrid Scalori, Alessandra Tavani, Silvano Gallus, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2008
Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin?Maria Francesca Donato, Francesca Agnelli, Cristina Rigamonti, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2022
Editorial: global liver fat accumulation and global health-towards a sustainable development goal. Authors' replyJeffrey V Lazarus, Henry E Mark, Mary E Rinella, et al.
The American Journal of Gastroenterology|October 3, 2002
Risk factors for focal nodular hyperplasia of the liver: an Italian case-control studyAstrid Scalori, Alessandra Tavani, Silvano Gallus, et al.
Tumori|April 16, 2009
Estimates of the incidence and prevalence of hepatocellular carcinoma in Italy in 2002 and projections for the years 2007 and 2012Cristina Bosetti, Cosetta Bianchi, Eva Negri, et al.
Hepatitis Monthly|August 11, 2012
Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft ReinfectionAlessio Aghemo, Sherrie Bhoori, Stella De Nicola, et al.
Blood|January 25, 2002
Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapyElena Santagostino, Maria Grazia Rumi, Monica Rivi, et al.
Pageof 38